In a speech at the FDA's Maryland campus, Robert F. Kennedy Jr. addressed agency staff undergoing significant workforce reductions. He urged them to resist corporate influences, indicating that the FDA's reluctance to approve alternative treatments is due to its ties with wealthy companies. Kennedy criticized how these ties have compromised public health by hampering oversight in crucial areas such as food safety and drug approval. He called for a transformation in priorities to protect the health of future generations, echoing sentiments of existing corruption within federal agencies.
Mr. Kennedy urged the staff to resist the temptation to serve a small group of wealthy companies at the cost of public health, emphasizing the need for bold action.
He suggested the agency's reluctance to approve alternative medicines stemmed from its subservience to corporate interests, rather than prioritizing public health.
Collection
[
|
...
]